NIA's Director of Regulatory Affairs, Dr Blanca Suarez Merino, will be presenting at the Nano2Clinic meeting in Zagreb on March 3rd. Her presentation, 'Regulatory aspects of clinical translation of nano-enabled products',  will focus on regulatory barriers and challenges hampering the potential of nanomedicine in clinical practice and will look into current activities envisaged to bridge the gap between lab research and industrial manufacturing.

The NanoHarmony project, in which NIA is a partner, will be hosting a meeting in Brussels. Using the NanoHarmony experiences in line with the aims of AMI2030 and the Malta Initiative, to will discuss the way forward for a European Test Method Strategy for safe innovation and a strong European industry.

Audience 

Online workshop by NIA member BNN